for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

S.Korea drug safety ministry approves J&J COVID-19 vaccine - News1

SEOUL, April 7 (Reuters) - South Korea’s food and drug safety ministry has granted final approval for the use of Johnson & Johnson’s coronavirus vaccine as the country pushes ahead with its vaccination campaign, the News1 agency reported on Wednesday.

The decision was made after a panel of South Korean advisers last week recommended that the single-dose shot was safe and effective, the report said.

The J&J vaccine marks the third COVID-19 vaccine to be authorised in South Korea, following ones from AstraZeneca and Pfizer/BioNTech, both of which require two doses. (Reporting by Sangmi Cha and Hyonhee Shin; Editing by Jacqueline Wong)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up